Golden hours in severe paraquat poisoning-the role of early haemoperfusion therapy

Raghavendra Rao, Rama Bhat, Swathi Pathadka, Sravan Kumar Chenji, Savio Dsouza

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)


Introduction: Paraquat is a commonly ingested poison especially in Southern India. There is no antidote for paraquat poison and consumption is often fatal. The usual cause of death is either acute lung injury or multi-organ failure. Aim: To evaluate the role of early haemoperfusion as a therapy in paraquat poisoned patients. Materials and Methods: This study was a retrospective analysis of patients admitted to a Tertiary Medical College Hospital between January 2012 and December 2015 with history of paraquat consumption, comparing outcomes in those who received only gastric lavage and symptomatic treatment with those who received haemoperfusion as a therapy. The role of early haemoperfusion (≤ 6 hours) vs late haemoperfusion (> 6 hours) in paraquat poisoned patients was also compared. The data of these patients was extracted and analysed with respect to age, sex, mode of treatment, the outcome in patients who received early and late haemoperfusion. results: A total of 101 patients were studied out of which 62 died. Deaths were more in those patients who received only gastric lavage with symptomatic treatment as therapy compared to those who received haemoperfusion i.e., 92.1% vs 42.9% respectively. We also found that, the survival rate was better in patients who received early haemoperfusion. conclusion: Early haemoperfusion was helpful in the management of severe paraquat poisoning and improved the survival rate in these patients.

Original languageEnglish
Pages (from-to)OC06-OC08
JournalJournal of Clinical and Diagnostic Research
Issue number2
Publication statusPublished - 01-02-2017

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Clinical Biochemistry


Dive into the research topics of 'Golden hours in severe paraquat poisoning-the role of early haemoperfusion therapy'. Together they form a unique fingerprint.

Cite this